Literature DB >> 12879987

Fulminant liver disease.

Frank Vinholt Schiødt1, William M Lee.   

Abstract

Fulminant liver disease, acute liver failure (ALF), is one of the most intriguing and challenging conditions in the entire field of internal medicine. ALF is defined as the onset of hepatic encephalopathy and coagulopathy in patients with no known underlying liver disease within 8 to 26 weeks of onset of illness. Many cases develop within a few days, dramatically transforming an otherwise healthy individual to a patient with a high risk for developing multi-organ failure and death.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12879987     DOI: 10.1016/s1089-3261(03)00026-6

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  13 in total

1.  Transjugular biopsy of an atypical focal nodular hyperplasia in a patient with acute liver failure clinical presentation.

Authors:  Roberto Miraglia; Luigi Maruzzelli; Marta Ida Minervini; Giuseppe Mamone; Settimo Caruso; Davide Cintorino; Angelo Luca; Bruno Gridelli
Journal:  Emerg Radiol       Date:  2008-05-08

2.  Outcome of acute liver failure in the elderly.

Authors:  Frank V Schiødt; Raymond T Chung; Michael L Schilsky; J Eileen Hay; Erik Christensen; William M Lee
Journal:  Liver Transpl       Date:  2009-11       Impact factor: 5.799

3.  Probiotic Lactobacillus casei Zhang reduces pro-inflammatory cytokine production and hepatic inflammation in a rat model of acute liver failure.

Authors:  Yuzhen Wang; Jiming Xie; Yunxu Li; Shichao Dong; Huan Liu; Junna Chen; Yan Wang; Shimin Zhao; Yong Zhang; Heping Zhang
Journal:  Eur J Nutr       Date:  2015-04-18       Impact factor: 5.614

4.  Rofecoxib-induced hepatotoxicity: a forgotten complication of the coxibs.

Authors:  Brian Yan; Yvette Leung; Stefan J Urbanski; Robert P Myers
Journal:  Can J Gastroenterol       Date:  2006-05       Impact factor: 3.522

5.  A novel acute lethal liver injury mouse model with visualization of NF-κB activity for treatment of severe acute liver injury.

Authors:  Huanjin Liao; Jun Cai; Lifang Zhang; Yanxia Peng; Ping Wu; Tong Xie; Qingjun Pan
Journal:  Am J Transl Res       Date:  2017-03-15       Impact factor: 4.060

6.  Inflammatory regulation by TLR3 in acute hepatitis.

Authors:  Xiaoyan Xiao; Peng Zhao; Daniel Rodriguez-Pinto; Dake Qi; Octavian Henegariu; Lena Alexopoulou; Richard A Flavell; F Susan Wong; Li Wen
Journal:  J Immunol       Date:  2009-08-26       Impact factor: 5.422

7.  New Strategies for Acute Liver Failure: Focus on Xenotransplantation Therapy.

Authors:  Luiz Anastácio Alves; André Bonavita; Kátia Quaresma; Elenilde Torres; Paulo Anastácio Furtado Pacheco; Vinícius Cotta-de-Almeida; Roberto Magalhães Saraiva
Journal:  Cell Med       Date:  2010-07-01

8.  Antileukoproteinase protects against hepatic inflammation, but not apoptosis in the response of D-galactosamine-sensitized mice to lipopolysaccharide.

Authors:  C Eipel; E Kidess; K Abshagen; K Leminh; M D Menger; H Burkhardt; B Vollmar
Journal:  Br J Pharmacol       Date:  2007-04-10       Impact factor: 8.739

9.  Point-of-care continuous (13)C-methacetin breath test improves decision making in acute liver disease: results of a pilot clinical trial.

Authors:  Gadi Lalazar; Tomer Adar; Yaron Ilan
Journal:  World J Gastroenterol       Date:  2009-02-28       Impact factor: 5.742

10.  Exogenous adenosine 5'-triphosphate does not improve survival in rats with acute liver failure.

Authors:  Erin P Becker; DongFeng Sun; Gerald Y Minuk
Journal:  Dig Dis Sci       Date:  2007-10-13       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.